Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
ekincare has raised a total funding of $22M since 2015 till date
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
